Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-046180
Filing Date
2025-03-27
Accepted
2025-03-27 17:03:30
Documents
98
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cvsi-20241231.htm   iXBRL 10-K 2781998
2 EX-2.6 cvsi-ex2_6.htm EX-2.6 489221
3 EX-2.7 cvsi-ex2_7.htm EX-2.7 26620
4 EX-19.1 cvsi-ex19_1.htm EX-19.1 96472
5 EX-21.1 cvsi-ex21_1.htm EX-21.1 8766
6 EX-23.1 cvsi-ex23_1.htm EX-23.1 4978
7 EX-31.1 cvsi-ex31_1.htm EX-31.1 13019
8 EX-31.2 cvsi-ex31_2.htm EX-31.2 13312
9 EX-32.1 cvsi-ex32_1.htm EX-32.1 8222
10 EX-32.2 cvsi-ex32_2.htm EX-32.2 7916
  Complete submission text file 0000950170-25-046180.txt   12887297

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cvsi-20241231.xsd EX-101.SCH 1732864
101 EXTRACTED XBRL INSTANCE DOCUMENT cvsi-20241231_htm.xml XML 2181998
Mailing Address 9530 PADGETT STREET SUITE 107 SAN DIEGO CA 92126
Business Address 9530 PADGETT STREET SUITE 107 SAN DIEGO CA 92126 866-290-2157
CV Sciences, Inc. (Filer) CIK: 0001510964 (see all company filings)

EIN.: 800944970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54677 | Film No.: 25780333
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)